BioRestorative Therapies Inc (BRTX)

[TheBurn]

https://t.co/QrjEVVaN4a

$BRTX announces expanded blinded data from its fully enrolled Phase 2 clinical trial evaluating BRTX-100, showing sustained improvements in both pain and function among patients with CLDD.

Learn more about the data presented at @ISCTglobal: https://t.co/QrjEVVaN4a#ISCT2026 pic.twitter.com/izb28J4S2F

— BioRestorative Therapies, Inc. (@BioRestorative) May 7, 2026